Aromatic L-Amino Acid Decarboxylase (AADC) DeficiencySymptoms, Doctors, Treatments, Advances & More
Learn About Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Atrium Health Neurology Specialty Care, A Facility Of Carolinas Medical Center
Danielle Doggett is a Neurologist practicing medicine in Charlotte, North Carolina. Dr. Doggett is rated as an Advanced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Parkinson's Disease, Movement Disorders, Essential Tremor, Drug Induced Dyskinesia, and Deep Brain Stimulation. Dr. Doggett is board certified in American Board Of Psychiatry And Neurology. Dr. Doggett is currently accepting new patients.
Aurora Neuroscience Innovation
Taylor Finseth is a Neurologist practicing medicine in Milwaukee, Wisconsin. Dr. Finseth is rated as an Advanced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Camptocormism, Parkinson's Disease, Movement Disorders, and Conversion Disorder. Dr. Finseth is board certified in American Board Of Psychiatry & Neurology.
Yin-hsiu Chien practices practicing medicine in Taiwan. Chien is rated as an Elite expert by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. They are also highly rated in 21 other conditions, according to our data. Their clinical expertise encompasses Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency, Pompe Disease, Citrullinemia, and Mucolipidosis Type 4.
Summary: The overall objective of this study is to determine the safety and efficacy of AAV2-hAADC delivered to the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) in children with aromatic L-amino acid decarboxylase (AADC) deficiency.